MENU
AVTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Avalo Therapeutics (AVTX) Ownership - Who owns Avalo Therapeutics?
Industry: @Pharmaceuticals Other
Profile
Industry
Pharmaceuticals Other
Address
540 Gaither Road
Phone
+1 410 522-8707
Employees
19
Web
https://www.avalotx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
98.15M
P/E Ratio
0.10
Total Cash
81.86M
Projected Growth
N/A
Total Debt
550K
Revenue
820K
Risk (Beta)
0.67
Dividend Yield
N/A
Total Cash/Share
7.82
Total Debt/Equity
N/A
Revenue/Share
0.16 USD as % of share price
Fundamentals
AVTX
Capitalization
98.1M
P/E Ratio
0.10
Risk (Beta)
0.67
Dividend Yield
N/A
Total Cash
81.9M
Total Cash/Share
7.82
Total Debt
550K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.16%
Revenue
820K
ROE
N/A
Book Value
21.1M
P/B Ratio
4.66
Cash Flow
N/A
Earnings
117.06
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
10K
Current Ratio
1.42
Current Revenue Per Employee
13105.26
Dividends Per Share - Security
N/A
EBITDA
-35.84M
Float
N/A
Float - Current
N/A
Gross Income Margin
386.75
Revenue To Assets
-12.74
Shares Held By Institutions
32.5M
Shares Outstanding - Current
10.5M
Total Liabilities
77.4M
Total Volume MTD
N/A
Value
-1
Gain YTD
3.077
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a clinical stage biopharmaceutical company
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
540 Gaither Road
Phone
+1 410 522-8707
Employees
19
Web
https://www.avalotx.com